![Raphaëlle Martin-Neuville](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Raphaëlle Martin-Neuville
Chief Operating Officer at Resilience SAS
Profile
Raphaëlle Martin-Neuville has worked as a Senior Associate at Aster Capital Partners SAS since 2018.
Additionally, they currently hold the position of Operations Manager at Resilience SAS, starting in 2021.
Raphaëlle Martin-Neuville active positions
Companies | Position | Start |
---|---|---|
Aster Capital Partners SAS
![]() Aster Capital Partners SAS Investment ManagersFinance Aster Capital Partners SAS (Aster Capital) is the French venture capital investment subsidiary of Schneider Electric SA (XP: SU), a world-leading electricity management and industrial automation group. Formerly known as Schneider Electric Ventures SAS, the firm was founded by Jean-Marc Bally in 2000 and changed their name to Aster Capital in 2010. Located in Paris with a representative office in China, the firm manages a venture capital fund sponsored by Schneider Electric and cooperates closely with the group's research scientists. | Private Equity Analyst | 01/10/2018 |
Resilience SAS
![]() Resilience SAS Packaged SoftwareTechnology Services Resilience SAS is a French technology-focused biomanufacturing company founded in 2020. The company is based in France, specifically in Garches, and has subsidiaries in the country. The company is building a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the treatments of today and tomorrow can be made quickly, safely, and at scale. Resilience seeks to advance the science of biopharmaceutical manufacturing and development to free its partners to focus on the discoveries that improve patients' lives and protect biopharmaceutical supply chains against future disruptions. Resilience is dedicated to broadening access to complex medicines such as biologics, vaccines, nucleic acid, cell/gene therapy modalities, and drug products. Additionally, the company has developed a mobile application aimed at improving the quality of life for patients by measuring, understanding, and alleviating symptoms related to treatments. The company was founded in 2020 by Céline Lazorthes, Drew Oetting, and Jonathan Benhamou, with Jonathan Benhamou serving as the CEO since then. | Chief Operating Officer | 01/02/2021 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Aster Capital Partners SAS
![]() Aster Capital Partners SAS Investment ManagersFinance Aster Capital Partners SAS (Aster Capital) is the French venture capital investment subsidiary of Schneider Electric SA (XP: SU), a world-leading electricity management and industrial automation group. Formerly known as Schneider Electric Ventures SAS, the firm was founded by Jean-Marc Bally in 2000 and changed their name to Aster Capital in 2010. Located in Paris with a representative office in China, the firm manages a venture capital fund sponsored by Schneider Electric and cooperates closely with the group's research scientists. | Finance |
Resilience SAS
![]() Resilience SAS Packaged SoftwareTechnology Services Resilience SAS is a French technology-focused biomanufacturing company founded in 2020. The company is based in France, specifically in Garches, and has subsidiaries in the country. The company is building a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the treatments of today and tomorrow can be made quickly, safely, and at scale. Resilience seeks to advance the science of biopharmaceutical manufacturing and development to free its partners to focus on the discoveries that improve patients' lives and protect biopharmaceutical supply chains against future disruptions. Resilience is dedicated to broadening access to complex medicines such as biologics, vaccines, nucleic acid, cell/gene therapy modalities, and drug products. Additionally, the company has developed a mobile application aimed at improving the quality of life for patients by measuring, understanding, and alleviating symptoms related to treatments. The company was founded in 2020 by Céline Lazorthes, Drew Oetting, and Jonathan Benhamou, with Jonathan Benhamou serving as the CEO since then. | Technology Services |
- Stock Market
- Insiders
- Raphaëlle Martin-Neuville